Abstract
Cardiovascular disease (CVD) is one of the most common diseases worldwide. The underlying pathogenesis of the disease has not yet been determined, but many factors have been identified. Tet methylcytosine dioxygenase 2 (TET2) is one of the epigenetic factors involved in regulating many genes. Therefore, based on the studies shown, this factor plays an important role in preventing the occurrence of CVD. TET2 has been shown to increase angiogenesis by expressing Robo4. It also increases the activity of Matrix metalloproteinases (MMPs) and stimulates the secretion of Vascular endothelial growth factor angiogenesis. On the other hand, it has been shown that TET2 regulates the expression of several genes and the development of the heart during the embryonic period due to its oxygenating role. TET2 has been shown to regulates the expression of the genes such as Ying Yang1 (YY1), Sox9b, Inhbaa and many other genes that ultimately lead to the differentiation of cardiomyocytes. On the other hand, it has been shown that some Long non coding RNA and MicroRNAs reduce TET2 expression and CVD. Finally, it is concluded that inducing TET2 expression can be a good therapeutic strategy to prevent or improve CVD.
Similar content being viewed by others
References
Haybar H, Jalali MT, Zayeri ZD (2018) What genetics tells us about cardiovascular disease in diabetic patients? Cardiovas Haematol Disord-Drug Targets (Former Curr Drug Targets- Cardiovas Haematol Disord) 18(2):147–152
Castro R, Rivera I, Struys EA, Jansen EE, Ravasco P, Camilo ME et al (2003) Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem 49(8):1292–1296
Zadeh FJ, Moadeli M, Soltanzadeh M, Janatmaksan F (2017) Effect of remote ischemic preconditioning on troponin I in CABG. Anesthesiol Pain Med 7(4):e12549
Fernández-Sanlés A, Sayols-Baixeras S, Subirana I, Degano IR, Elosua R (2017) Association between DNA methylation and coronary heart disease or other atherosclerotic events: a systematic review. Atherosclerosis 263:325–333
Leenen FA, Muller CP, Turner JD (2016) DNA methylation: conducting the orchestra from exposure to phenotype? Clin Epigenet 8(1):92
Fuke C, Shimabukuro M, Petronis A, Sugimoto J, Oda T, Miura K et al (2004) Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study. Ann Hum Genet 68(3):196–204
Bussaglia E, Antón R, Nomdedéu JF, Fuentes-Prior P (2019) TET2 missense variants in human neoplasia. A proposal of structural and functional classification. Mol Genet Genom Med 7:e772
Valinluck V, Sowers LC (2007) Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Can Res 67(3):946–950
Hashimoto H, Liu Y, Upadhyay AK, Chang Y, Howerton SB, Vertino PM et al (2012) Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation. Nucleic Acids Res 40(11):4841–4849
Lou H, Li H, Ho KJ, Cai L, Huang AS, Shank TR et al (2019) The human TET2 gene contains three distinct promoter regions with differing tissue and developmental specificities. Front Cell Dev Biol 7:99
Zhuang J, Luan P, Li H, Wang K, Zhang P, Xu Y et al (2017) The Yin-Yang dynamics of DNA methylation is the key regulator for smooth muscle cell phenotype switch and vascular remodeling. Arterioscler Thromb Vasc Biol 37(1):84–97
Payami B, Jafarizade M, Mousavi SSB, Sattari S-A, Nokhostin F (2016) Prevalence and predictors of atherosclerotic renal artery stenosis in hypertensive patients undergoing simultaneous coronary and renal artery angiography; a cross-sectional study. J Renal Inj Prev 5(1):34
Tanaka T, Izawa K, Maniwa Y, Okamura M, Okada A, Yamaguchi T et al (2018) ETV2-TET1/TET2 complexes induce endothelial cell-specific Robo4 expression via promoter demethylation. Sci Rep 8(1):5653
Gould RA, Aziz H, Woods CE, Seman-Senderos MA, Sparks E, Preuss C et al (2019) ROBO4 variants predispose individuals to bicuspid aortic valve and thoracic aortic aneurysm. Nat Genet 51(1):42
Bedell VM, Yeo S-Y, Park KW, Chung J, Seth P, Shivalingappa V et al (2005) Roundabout4 is essential for angiogenesis in vivo. Proc Natl Acad Sci 102(18):6373–6378
Seth P, Lin Y, Hanai J-i, Shivalingappa V, Duyao MP, Sukhatme VP (2005) Magic roundabout, a tumor endothelial marker: expression and signaling. Biochem Biophys Res Commun 332(2):533–541
Shirakura K, Ishiba R, Kashio T, Sakai M, Fukushima Y, Yamamoto N et al (2018) Endothelial Robo4 regulates IL-6 production by endothelial cells and monocytes via a crosstalk mechanism in inflammation. Biochem Biophys Res Commun 495(1):801–806
Meschiari CA, Pinheiro LC, Guimaraes DA, Gerlach RF, Tanus-Santos JE (2016) Sodium nitrite attenuates MMP-9 production by endothelial cells and may explain similar effects of atorvastatin. Naunyn-Schmiedeberg’s Arch Pharmacol 389(2):223–231
Duraisamy AJ, Mishra M, Kowluru RA (2017) Crosstalk between histone and DNA methylation in regulation of retinal matrix metalloproteinase-9 in diabetes. Invest Ophthalmol Vis Sci 58(14):6440–6448
Chen R, Cai X, Liu J, Bai B, Li X (2018) Sphingosine 1-phosphate promotes mesenchymal stem cell-mediated cardioprotection against myocardial infarction via ERK1/2-MMP-9 and Akt signaling axis. Life Sci 215:31–42
Toba H, Cannon PL, Yabluchanskiy A, Iyer RP, D’Armiento J, Lindsey ML (2016) Transgenic overexpression of macrophage matrix metalloproteinase-9 exacerbates age-related cardiac hypertrophy, vessel rarefaction, inflammation, and fibrosis. Am J Physiol-Heart Circ Physiol 312(3):H375–H383
Deleon-Pennell KY, Altara R, Yabluchanskiy A, Modesti A, Lindsey ML (2015) The circular relationship between matrix metalloproteinase-9 and inflammation following myocardial infarction. IUBMB Life 67(8):611–618
Sasagawa S, Nishimura Y, Sawada H, Zhang E, Okabe S, Murakami S et al (2016) Comparative transcriptome analysis identifies CCDC80 as a novel gene associated with pulmonary arterial hypertension. Front Pharmacol 7:142
Gong D, Zhang Q, Chen L-Y, Yu X-H, Wang G, Zou J et al (2019) Coiled-coil domain-containing 80 accelerates atherosclerosis development through decreasing lipoprotein lipase expression via ERK1/2 phosphorylation and TET2 expression. Eur J Pharmacol 843:177–189
Qi X-F, Chen Z-Y, Xia J-B, Zheng L, Zhao H, Pi L-Q et al (2015) FoxO3a suppresses the senescence of cardiac microvascular endothelial cells by regulating the ROS-mediated cell cycle. J Mol Cell Cardiol 81:114–126
Sano S, Oshima K, Wang Y, MacLauchlan S, Katanasaka Y, Sano M et al (2018) Tet2-mediated clonal hematopoiesis accelerates experimental heart failure through an IL-1β/NLRP3 inflammasome mechanism. J Am Coll Cardiol 71:875–886
Bogdanović O, Smits AH, de la Calle ME, Tena JJ, Ford E, Williams R et al (2016) Active DNA demethylation at enhancers during the vertebrate phylotypic period. Nat Genet 48(4):417–426
Fang S, Li J, Xiao Y, Lee M, Guo L, Han W et al (2019) Tet inactivation disrupts YY1 binding and long-range chromatin interactions during embryonic heart development. Nat Commun 10(1):1–18
Lan Y, Pan H, Li C, Banks KM, Sam J, Ding B et al (2019) TETs regulate proepicardial cell migration through extracellular matrix organization during zebrafish cardiogenesis. Cell Rep 26(3):720–732
Luxán G, D’Amato G, MacGrogan D, de la Pompa JL (2016) Endocardial notch signaling in cardiac development and disease. Circ Res 118(1):e1–e18
Li X, Yue X, Pastor WA, Lin L, Georges R, Chavez L et al (2016) Tet proteins influence the balance between neuroectodermal and mesodermal fate choice by inhibiting Wnt signaling. Proc Natl Acad Sci 113(51):E8267–E8276
Terragni J, Zhang G, Sun Z, Pradhan S, Song L, Crawford GE et al (2014) Notch signaling genes: myogenic DNA hypomethylation and 5-hydroxymethylcytosine. Epigenetics 9(6):842–850
Liu XH, De Gasperi R, Bauman WA, Cardozo CP (2018) Nandrolone-induced nuclear accumulation of MyoD protein is mediated by Numb, a Notch inhibitor, in C2C12 myoblasts. Physiol Rep 6(1):e13520
Greco CM, Kunderfranco P, Rubino M, Larcher V, Carullo P, Anselmo A et al (2016) DNA hydroxymethylation controls cardiomyocyte gene expression in development and hypertrophy. Nat Commun 7(1):1–15
Zarzour A, Kim HW, Weintraub NL (2019) Epigenetic regulation of vascular diseases. Arterioscler Thromb Vasc Biol 39(6):984–990
Javaherforoosh Zadeh F, Janatmakan F, Soltanzadeh M, Zamankhani M (2019) Investigating the effect of fibrinogen injection on bleeding in coronary artery bypass surgery: a clinical trial. Anesthesiol Pain Med 9(4):92165
Dorsheimer L, Assmus B, Rasper T, Ortmann CA, Ecke A, Abou-El-Ardat K et al (2019) Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure. JAMA Cardiol 4(1):25–33
Nakatsukasa H, Oda M, Yin J, Chikuma S, Ito M, Koga-Iizuka M et al (2019) Loss of TET proteins in regulatory T cells promotes abnormal proliferation, Foxp3 destabilization and IL-17 expression. Int Immunol 31(5):335–347
Seyedian SS, Nokhostin F, Malamir MD (2019) A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J Med Life 12(2):113
Ichiyama K, Chen T, Wang X, Yan X, Kim B-S, Tanaka S et al (2015) The methylcytosine dioxygenase Tet2 promotes DNA demethylation and activation of cytokine gene expression in T cells. Immunity 42(4):613–626
Janatmakan F, Nesioonpour S, Zadeh FJ, Teimouri A, Vaziri M (2019) Comparing the effect of clonidine and dexmedetomidine on intraoperative bleeding in spine surgery. Anesthesiol Pain Med 9(1):83967
Wu T, Peng Y, Yan S, Li N, Chen Y, Lan T (2018) Andrographolide ameliorates atherosclerosis by suppressing pro-inflammation and ROS generation-mediated foam cell formation. Inflammation 41(5):1681–1689
Haybar H, Shahrabi S, Rezaeeyan H, Shirzad R, Saki N (2019) Endothelial cells: from dysfunction mechanism to pharmacological effect in cardiovascular disease. Cardiovasc Toxicol 19(1):13–22
Zhaolin Z, Jiaojiao C, Peng W, Yami L, Tingting Z, Jun T et al (2019) OxLDL induces vascular endothelial cell pyroptosis through miR-125a-5p/TET2 pathway. J Cell Physiol 234(5):7475–7491
Man SM, Karki R, Kanneganti TD (2017) Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev 277(1):61–75
Hoseini Z, Sepahvand F, Rashidi B, Sahebkar A, Masoudifar A, Mirzaei H (2018) NLRP3 inflammasome: its regulation and involvement in atherosclerosis. J Cell Physiol 233(3):2116–2132
Ji K-T, Qian L, Nan J-l, Xue Y-J, Zhang S-Q, Wang G-Q et al (2015) Ox-LDL induces dysfunction of endothelial progenitor cells via activation of NF-B. BioMed Res Int 2015:8
Liu M, Yu P, Jiang H, Yang X, Zhao J, Zou Y et al (2017) The essential role of Pin1 via NF-κB signaling in vascular inflammation and atherosclerosis in ApoE−/− mice. Int J Mol Sci 18(3):644
Peng J, Tang Z-H, Ren Z, He B, Zeng Y, Liu L-S et al (2017) TET2 protects against oxLDL-induced HUVEC dysfunction by upregulating the CSE/H2S system. Front Pharmacol 8:486
Huang S, Li H, Ge J (2015) A cardioprotective insight of the cystathionine γ-lyase/hydrogen sulfide pathway. IJC Heart & Vasc 7:51–57
Wirawan E, Lippens S, Vanden Berghe T, Romagnoli A, Fimia GM, Piacentini M et al (2012) Beclin1: a role in membrane dynamics and beyond. Autophagy 8(1):6–17
Li Y, Li J, Zhang P, Jiang X, Pan Z, Zheng W et al (2020) LncRNA-LET relieves hypoxia-induced injury in H9c2 cells through regulation of miR-138. J Cell Biochem 121(1):259–268
Greco S, Gaetano C, Martelli F (2019) Long noncoding competing endogenous rna networks in age-associated cardiovascular diseases. Int J Mol Sci 20(12):3079
Ren S, Xu Y (2019) AC016405. 3, a novel long noncoding RNA, acts as a tumor suppressor through modulation of TET2 by microRNA-19a-5p sponging in glioblastoma. Cancer Sci 110(5):1621
Deng W, Wang J, Zhang J, Cai J, Bai Z, Zhang Z (2016) TET2 regulates LncRNA-ANRIL expression and inhibits the growth of human gastric cancer cells. IUBMB Life 68(5):355–364
Tan P, Guo Y-H, Zhan J-K, Long L-M, Xu M-L, Ye L et al (2019) LncRNA-ANRIL inhibits cell senescence of vascular smooth muscle cells by regulating miR-181a/Sirt1. Biochem Cell Biol 97(5):571–580
Maiese K (2017) Harnessing the power of SIRT1 and non-coding RNAs in vascular disease. Curr Neurovasc Res 14(1):82–88
Yao H, Duan M, Lin L, Wu C, Fu X, Wang H et al (2017) TET2 and MEG3 promoter methylation is associated with acute myeloid leukemia in a Hainan population. Oncotarget 8(11):18337
Piccoli M-T, Gupta SK, Viereck J, Foinquinos A, Samolovac S, Kramer FL et al (2017) Inhibition of the cardiac fibroblast–enriched lncRNA Meg3 prevents cardiac fibrosis and diastolic dysfunction. Circ Res 121(5):575–583
Wu H, Zhao Z-A, Liu J, Hao K, Yu Y, Han X et al (2018) Long noncoding RNA Meg3 regulates cardiomyocyte apoptosis in myocardial infarction. Gene Ther 25(8):511
Zhang S, Gao S, Wang Y, Jin P, Lu F (2019) lncRNA SRA1 promotes the activation of cardiac myofibroblasts through negative regulation of miR-148b. DNA Cell Biol 38(4):385–394
Miscianinov V, Martello A, Rose L, Parish E, Cathcart B, Mitić T et al (2018) MicroRNA-148b targets the TGF-β pathway to regulate angiogenesis and endothelial-to-mesenchymal transition during skin wound healing. Mol Ther 26(8):1996–2007
Jiang Y, Zhuang J, Lin Y, Wang X, Chen J, Han F (2019) Long noncoding RNA SNHG6 contributes to ventricular septal defect formation via negative regulation of miR-101 and activation of Wnt/β-catenin pathway. Die Pharm-An Int J Pharm Sci 74(1):23–28
Sun R, Zhang L (2019) Long non-coding RNA MALAT1 regulates cardiomyocytes apoptosis after hypoxia/reperfusion injury via modulating miR-200a-3p/PDCD4 axis. Biomed Pharmacother 111:1036–1045
Huang S, Tao W, Guo Z, Cao J, Huang X (2019) Suppression of long noncoding RNA TTTY15 attenuates hypoxia-induced cardiomyocytes injury by targeting miR-455-5p. Gene 701:1–8
Kalfon R, Haas T, Shofti R, Moskovitz J, Schwartz O, Suss-Toby E et al (2017) c-Jun dimerization protein 2 (JDP2) deficiency promotes cardiac hypertrophy and dysfunction in response to pressure overload. Int J Cardiol 249:357–363
Yan H, Liang H, Liu L, Chen D, Zhang Q (2019) Long noncoding RNA NEAT1 sponges miR-125a-5p to suppress cardiomyocyte apoptosis via BCL2L12. Mol Med Rep 19(5):4468–4474
Liu K, Liu C, Zhang Z (2019) lncRNA GAS5 acts as a ceRNA for miR-21 in suppressing PDGF-bb-induced proliferation and migration in vascular smooth muscle cells. J Cell Biochem 120(9):15233–15240
Wang P, Yuan Y (2019) LncRNA-ROR alleviates hypoxia-triggered damages by downregulating miR-145 in rat cardiomyocytes H9c2 cells. J Cell Physiol 234(12):23695–23704
Acknowledgements
We wish to thank all our colleagues in Golestan Hospital and Allied Health Sciences School, Ahvaz Jundishapur University of Medical Sciences.
Author information
Authors and Affiliations
Contributions
HR has conceived the manuscript and revised it. FJZ, and AS wrote the manuscript. ZD and ND design table and figure. TA conduct revise and edited grammar English.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zadeh, F.J., Akbari, T., zayeri, Z.D. et al. The role of molecular mechanism of Ten-Eleven Translocation2 (TET2) family proteins in pathogenesis of cardiovascular diseases (CVDs). Mol Biol Rep 47, 5503–5509 (2020). https://doi.org/10.1007/s11033-020-05602-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-020-05602-4